See more : Altarea SCA (ALTA.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Dalrada Financial Corporation (DFCO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Dalrada Financial Corporation, a leading company in the Consulting Services industry within the Industrials sector.
- Topdanmark A/S (TOP.CO) Income Statement Analysis – Financial Results
- IReader Technology Co., Ltd. (603533.SS) Income Statement Analysis – Financial Results
- KSS Limited (KSERASERA.NS) Income Statement Analysis – Financial Results
- Aizawa Securities Group Co.,Ltd. (8708.T) Income Statement Analysis – Financial Results
- Acadia Realty Trust (AKR) Income Statement Analysis – Financial Results
Dalrada Financial Corporation (DFCO)
About Dalrada Financial Corporation
Dalrada Financial Corporation and its subsidiaries provide clean energy, healthcare, technology, and precision engineering solutions. It operates through Engineering, Health, Information Technology, Education, and Corporate. The company engages in the manufacture and distribution of medical disposables, hospital equipment and furniture, medical devices, and laboratory and dental products, as well as sanitizing, disinfectant, and PPE products and services; and provision of mechanical contract services. It also provides advanced solutions for the harvesting and recycling of energy to maximize the capture and reuse of thermal energy for integrated heating and cooling applications, such as industrial, commercial, and residential sectors. In addition, the company offers software and technology solutions that specializes in test engineering, accessibility engineering, product engineering and application modernization; cleaning solutions using electrostatic machines to spray and deodorize residential spaces, healthcare facilities, hospitality, transportation, manufacturing, automotive, schools/education systems, and other facilities. Further, it provides trained nursing and medical assistants for hospitals and home health facilities; and regenerative therapy as a potential solution for the prevention, detection, and treatment of cellular breakdown associated with aging and various other conditions, as well as explores various products and services within the immunization and personal protective equipment industry. The company has operations in Malaysia, India, the United Kingdom, and the United States. Dalrada Financial Corporation was founded in 1982 and is based in Escondido, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 29.74M | 19.27M | 3.41M | 1.18M | 72.16K | 0.00 | 70.38M | 19.48M | 13.53M | 4.19M | 25.25M | 3.45M | 2.55M | 17.30M | 34.40M | 30.60M | 11.60M | 14.40M | 11.10M | 10.20M | 10.30M | 7.20M | 10.50M | 9.50M | 9.30M | 4.20M | 1.80M |
Cost of Revenue | 20.68M | 8.76M | 2.47M | 625.92K | 75.00K | 0.00 | 63.93M | 16.53M | 10.30M | 2.30M | 23.20M | 2.74M | 1.87M | 13.30M | 21.80M | 15.50M | 9.60M | 11.60M | 9.80M | 4.70M | 4.90M | 5.50M | 8.10M | 8.10M | 7.20M | 2.80M | 1.40M |
Gross Profit | 9.06M | 10.51M | 934.72K | 552.24K | -2.84K | 0.00 | 6.45M | 2.95M | 3.22M | 1.89M | 2.05M | 710.00K | 679.00K | 4.00M | 12.60M | 15.10M | 2.00M | 2.80M | 1.30M | 5.50M | 5.40M | 1.70M | 2.40M | 1.40M | 2.10M | 1.40M | 400.00K |
Gross Profit Ratio | 30.46% | 54.53% | 27.44% | 46.87% | -3.94% | 0.00% | 9.17% | 15.13% | 23.84% | 45.13% | 8.13% | 20.57% | 26.66% | 23.12% | 36.63% | 49.35% | 17.24% | 19.44% | 11.71% | 53.92% | 52.43% | 23.61% | 22.86% | 14.74% | 22.58% | 33.33% | 22.22% |
Research & Development | 120.00K | 657.00K | 520.51K | 471.96K | 50.05K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250.00K | 2.05M | 2.20M | 2.50M | 4.20M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 29.47M | 20.07M | 8.98M | 2.77M | 721.85K | 91.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 29.47M | 20.07M | 8.98M | 2.77M | 721.85K | 91.98K | 11.19M | 5.58M | 4.20M | 7.59M | 12.44M | 8.72M | 7.78M | 13.70M | 10.30M | 9.40M | 3.20M | 4.40M | 4.40M | 4.40M | 4.40M | 6.00M | 5.20M | 3.50M | 3.80M | 2.90M | 1.70M |
Other Expenses | 433.56K | 308.53K | 114.40K | 1.23M | 2.26M | -183.97K | 0.00 | 1.35M | 0.00 | 0.00 | 0.00 | 0.00 | 3.33M | 4.80M | 700.00K | 900.00K | 400.00K | 800.00K | 700.00K | 300.00K | 200.00K | 300.00K | 100.00K | 200.00K | 200.00K | 200.00K | 200.00K |
Operating Expenses | 30.02M | 20.72M | 9.50M | 3.24M | 771.90K | 91.98K | 11.19M | 6.93M | 4.20M | 7.59M | 12.44M | 8.97M | 13.16M | 20.70M | 13.50M | 14.50M | 3.60M | 5.20M | 5.10M | 4.70M | 4.60M | 6.30M | 5.30M | 3.70M | 4.00M | 3.10M | 1.90M |
Cost & Expenses | 50.70M | 29.48M | 11.98M | 3.87M | 846.89K | 91.98K | 75.12M | 23.46M | 14.50M | 9.89M | 35.64M | 11.71M | 15.03M | 34.00M | 35.30M | 30.00M | 13.20M | 16.80M | 14.90M | 9.40M | 9.50M | 11.80M | 13.40M | 11.80M | 11.20M | 5.90M | 3.30M |
Interest Income | 79.76K | 4.45K | 6.28K | 8.77K | 853.18K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 2.55M | 1.30M | 670.27K | 1.04M | 853.18K | 945.24K | 2.70M | 1.71M | 1.93M | 0.00 | 3.30M | 0.00 | 0.00 | 0.00 | 0.00 | 100.00K | 100.00K | 100.00K | 100.00K | 0.00 | 0.00 | 400.00K | 400.00K | 300.00K | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 707.57K | 252.94K | 112.50K | 46.60K | 774.74K | 91.98K | 1.34M | 510.00K | 1.18M | 1.07M | 972.00K | 806.00K | 3.33M | 4.80M | 700.00K | 900.00K | -400.00K | -800.00K | -700.00K | -300.00K | -200.00K | 300.00K | 100.00K | 200.00K | 200.00K | 200.00K | 200.00K |
EBITDA | -17.37M | -9.88M | 783.99K | -1.39M | 1.22M | -91.98K | -3.40M | -3.47M | 203.00K | -4.62M | -9.42M | -7.45M | -9.16M | -11.90M | -200.00K | 1.40M | -1.20M | -1.60M | -3.10M | 1.10M | 1.00M | -4.30M | -2.80M | -2.10M | -1.70M | -1.50M | -1.30M |
EBITDA Ratio | -58.40% | -49.73% | -243.88% | -223.53% | -1,073.71% | 0.00% | -19.69% | -18.15% | 1.45% | -166.85% | -37.29% | -168.77% | -364.90% | -32.37% | 25.58% | 4.58% | 7.76% | -11.11% | -27.93% | 10.78% | 16.50% | -55.56% | -49.52% | -41.05% | -35.48% | -54.76% | -100.00% |
Operating Income | -20.96M | -10.22M | -8.57M | -2.69M | -774.74K | -91.98K | -4.74M | -3.98M | -972.00K | -5.70M | -10.39M | -8.26M | -12.48M | -16.70M | -900.00K | 600.00K | -1.60M | -2.40M | -3.80M | 800.00K | 800.00K | -4.60M | -2.90M | -2.30M | -1.90M | -1.70M | -1.50M |
Operating Income Ratio | -70.48% | -53.03% | -251.57% | -228.23% | -1,073.71% | 0.00% | -6.73% | -20.44% | -7.19% | -135.92% | -41.14% | -239.28% | -490.15% | -96.53% | -2.62% | 1.96% | -13.79% | -16.67% | -34.23% | 7.84% | 7.77% | -63.89% | -27.62% | -24.21% | -20.43% | -40.48% | -83.33% |
Total Other Income/Expenses | 332.24K | -1.00M | 8.57M | 211.54K | 1.14M | -945.24K | 7.77M | -121.00K | -1.92M | -1.16M | -3.30M | -1.63M | -1.71M | -8.10M | -9.00M | -13.00K | -2.10M | 0.00 | 0.00 | 0.00 | -700.00K | -300.00K | 2.10M | 1.80M | 1.60M | 800.00K | 500.00K |
Income Before Tax | -20.63M | -11.44M | 1.22K | -2.48M | 365.85K | -1.04M | 3.03M | -4.28M | -2.90M | -6.86M | -13.69M | -9.89M | -12.35M | -24.80M | -9.90M | 600.00K | -3.70M | 0.00 | 0.00 | 800.00K | 100.00K | -4.90M | -800.00K | -500.00K | -300.00K | -900.00K | -1.00M |
Income Before Tax Ratio | -69.36% | -59.37% | 0.04% | -210.29% | 507.03% | 0.00% | 4.30% | -21.96% | -21.40% | -163.60% | -54.20% | -286.44% | -484.69% | -143.35% | -28.78% | 1.96% | -31.90% | 0.00% | 0.00% | 7.84% | 0.97% | -68.06% | -7.62% | -5.26% | -3.23% | -21.43% | -55.56% |
Income Tax Expense | 0.00 | 132.51K | 694.46K | 1.03M | -1.99M | -91.98K | 40.00K | 238.00K | -1.07M | 1.16M | 0.00 | 1.63M | 1.71M | 300.00K | 9.30M | -200.00K | 2.80M | 1.30M | 1.60M | 100.00K | 1.10M | 800.00K | 100.00K | -1.40M | -1.50M | -900.00K | -500.00K |
Net Income | -20.29M | -11.57M | -693.24K | -3.51M | 2.36M | -1.04M | 2.62M | -4.22M | 102.00K | -6.86M | -13.69M | -9.89M | -14.20M | -25.10M | -10.20M | 800.00K | -3.60M | -2.10M | -4.00M | 700.00K | 100.00K | -5.40M | -900.00K | -900.00K | -400.00K | -800.00K | -1.00M |
Net Income Ratio | -68.24% | -60.06% | -20.35% | -297.76% | 3,270.20% | 0.00% | 3.73% | -21.66% | 0.75% | -163.60% | -54.20% | -286.44% | -557.44% | -145.09% | -29.65% | 2.61% | -31.03% | -14.58% | -36.04% | 6.86% | 0.97% | -75.00% | -8.57% | -9.47% | -4.30% | -19.05% | -55.56% |
EPS | -0.24 | -0.16 | -0.01 | -0.06 | 0.05 | -0.02 | 0.63 | -1.28 | 0.06 | -14.23 | -224.38 | -300.80 | -545.05 | -6.48K | -3.60K | 280.00 | -1.26K | -735.04 | -1.40K | 245.01 | 35.00 | -1.89K | -315.02 | -315.02 | -140.01 | -280.01 | -350.02 |
EPS Diluted | -0.24 | -0.16 | -0.01 | -0.06 | 0.02 | -0.02 | 0.35 | -1.28 | 0.06 | -14.23 | -224.38 | -300.80 | -545.05 | -6.48K | -3.60K | 240.00 | -1.26K | -735.04 | -1.40K | 245.01 | 35.00 | -1.89K | -315.02 | -315.02 | -140.01 | -280.01 | -350.02 |
Weighted Avg Shares Out | 83.76M | 72.22M | 70.32M | 56.80M | 47.43M | 47.28M | 4.11M | 3.29M | 1.66M | 481.58K | 61.01K | 32.87K | 26.05K | 3.87K | 2.83K | 2.50K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K |
Weighted Avg Shares Out (Dil) | 83.76M | 72.22M | 128.95M | 56.80M | 102.58M | 47.28M | 19.35M | 3.29M | 1.66M | 481.58K | 61.01K | 32.87K | 26.05K | 3.87K | 2.83K | 2.92K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K | 2.86K |
Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million
Dalrada Financial Corporation's Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market
Dalrada Financial Corporation Subsidiary, Dalrada Home Corp., forms Advisory Board and Announces Inaugural Members
Dalrada Financial Corporation Enters $104 Billion Carbon Credit Market with Data Mining Innovation
Dalrada Financial Corporation Announces Heat Pump Product Expansion, Enters Home and Residential Heat Pump Market
Dalrada Corporation Announces Authorized Share Reduction Highlighting Huge Growth Potential in 8-K Filing
Dalrada Reports 54.3% Revenue Increase and Positive Net Equity in Annual 10-K
Dalrada Technology Spain Announces Agreement with Crown Glory Holding to Build and Install up to 4,500 Heat Pumps
Dalrada Corporation Announces Further Global Expansion; Establishes Dalrada Technologies Morocco
Trucept Announces 665% Increase In Operating Income
Source: https://incomestatements.info
Category: Stock Reports